TrialJournal of endocrinological investigation2018

Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency.

G Johannsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.